Wang, Mengfan
Du, Siyao
Gao, Si
Zhao, Ruimeng
Liu, Shasha
Jiang, Wenhong
Peng, Can
Chai, Ruimei
Zhang, Lina
Clinical trials referenced in this document:
Documents that mention this clinical trial
MRI-based tumor shrinkage patterns after early neoadjuvant therapy in breast cancer: correlation with molecular subtypes and pathological response after therapy
https://doi.org/10.1186/s13058-024-01781-1
Funding for this research was provided by:
National Natural Science Foundation of China (82302165, 81971695)
Liaoning Provincial Science and Technology Plan (2022-BS-119)
Liaoning Province Applied Basic Research Program (2022JH2/101300027)
Article History
Received: 11 November 2023
Accepted: 9 February 2024
First Online: 12 February 2024
Declarations
:
: The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board (or Ethics Committee) of the First Hospital of China Medical University (Ethic code: 2019-33-2 with date of approval 6 March 2019). Participants were enrolled after providing their written informed consent.
: Not applicable.
: The authors declare that they have no competing interests.